Larry M. Simonsmeier Writing Award
The American Society for Pharmacy Law (ASPL) is a nationwide organization with the purposes of: (i) furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues ("Pharmacy Law"); (ii) communicating accurate legal educational information; and (iii) providing education opportunities for pharmacists, attorneys, and others who are interested in Pharmacy Law.
ASPL recognizes outstanding scholarship related to Pharmacy Law with the Simonsmeier Award. The Award recognizes an outstanding paper relating to the interests of ASPL published during the prior two years (2014-2016). The 2017 Award includes an honorarium plus support for travel to the ASPL Developments in Pharmacy Law Seminar XXVIII in Scottsdale, AZ, November 2-5, 2017.
The Award is named in honor of the late Larry Simonsmeier (1944-2009), who was a pharmacist and attorney, professor and dean of Washington State University College of Pharmacy, president of ASPL, and editor of the Rx Ipsa Loquitur for more than twenty years.
Papers related to Pharmacy Law, as defined above, published in or accepted for publication in any English-language peer-reviewed journal (including law reviews) during the period from January 2014 through December 2016 are eligible. Interested parties are invited to nominate published papers written by themselves or other authors. Authors may submit manuscripts that are in press.
Submission of Nominations
Nominations should provide the name, address, daytime telephone number, and e-mail address of the nominator, a reprint of the full paper, and a complete journal citation for the paper being nominated. If an author is submitting a manuscript that is in press, the copy of the manuscript should be accompanied by documentation from the journal editor of the status of the paper, and should include contact information for the journal editor. The deadline for submission of nominations for the Larry M. Simonsmeier Award is June 30, 2017.
Nominations should be addressed to:
Education & Scholarship Committee
Questions may be directed to ASPL at:
January 19, 2017
MEDICAID PHARMACIST PRESCRIBING
CMS tells states they should be flexible in facilitating access to drug therapy by recognizing the expanded scope of pharmacists
On January 17, the Center for Medicaid and CHIP Services (CMCS) within CMS, announced to states that in CMCS’ view, they have “flexibilities” to “facilitate timely access to specific drugs by expanding the scope of practice and services that can be provided by pharmacists, including dispensing drugs based on their own independently initiated prescriptions, collaborative practice agreements ... ‘standing orders’ issued by the state, or other predetermined protocols” for Medicaid beneficiaries.
The announcement cites naloxone distribution, tobacco cessation therapy, immunizations, and emergency contraception as examples of options that states could choose to pay for when delivered by pharmacists to Medicaid beneficiaries. [USDHHS, CMS, CMCS. State flexibility to facilitate timely access to drug therapy by expanding the scope of pharmacy practice using collaborative practice agreements, standing orders, or other predetermined protocols. CMCS Informational Bulletin 2017 Jan 17; http://bit.ly/2iT32GW]
SAVE THE DATE
2017 DPLXXVIII Seminar
November 2-5, 2017